Current Respiratory Medicine Reviews - Volume 18, Issue 3, 2022

Pulmonary rehabilitation is a multidisciplinary intervention recommended by international guidelines in managing COVID-19 patients and/or post-COVID-19 conditions with mid-and long-term complications of the initial illness. Physiotherapy-based pulmonary rehabilitation has received considerable attention since the COVID-19 pandemic, with supervised exercise training probably the most important component. Curren Read More

The World Health Organization (WHO) considers tuberculosis to be the most dangerous chronic communicable disease in the world, infecting two billion people or one-third of the world’s population. Tuberculosis (TB) caused by Mycobacterium tuberculosis remains a leading cause of mortality worldwide into the 21st century. Tuberculosis is second only to AIDS among other infectious diseases causing deaths worldwide. The em Read More

Exercise training is paramount in improving aerobic capacity, lung function, reducing the symptoms of dyspnea, and reconditioning the lean skeletal muscles. Many literature and guidelines have advocated the importance of exercise intervention in addressing the secondary impairment to post covid-19 infection, including home-based therapy and telerehabilitation. Pulmonary hypertension (PH) was previously thought to Read More

Airway involvement results from long-standing rheumatoid arthritis leading to severe pulmonary complications, correlated with increased mortality and socioeconomic costs. Different types of pulmonary lesions, including pulmonary rheumatoid nodule, pulmonary arteritis, diffuse interstitial fibrosis, and rheumatoid pneumoconiosis or Caplan's syndrome, are believed to be related to rheumatoid arthritis (R.A.). The above cha Read More

Tuberculosis is one of the most common and oldest human afflictions caused by the deadly pathogen, Mycobacterium tuberculosis. Its infection is drastically increasing worldwide with time despite the application of various antibiotics and live attenuated vaccines. The major risk factor associated with tuberculosis is the long-term malfunction of the respiratory system that increases deaths, whereas the continuous emer Read More

Asthma is a noncommunicable, chronic respiratory disease affecting 339 million individuals globally. The SNAPSHOT study suggests a prevalence rate of 6.4% in the Middle East region and 7.6% in the Gulf region alone, causing a significant healthcare burden. The management of severe asthma poses a significant challenge, thus accounting for suboptimal disease control. Diagnosis of severe asthma is quite difficult, consi Read More

Objective: Electrical Impedance Tomography (EIT) has emerged as a non-invasive, radiation- free imaging modality that allows monitoring at the patient's bedside, providing real-time information on the regional distribution of pulmonary ventilation. Although there has been increasing research on EIT in Intensive Care Units (ICUs), few studies use this tool in patients with spontaneous breathing. The objective is to descri Read More

Background: Inhaled corticosteroids (ICS) have an essential and established role in the treatment of asthma. Both systemic and local adverse effects may accompany the long-term use of ICS. Systemic adverse drug reactions (ADRs) of ICS are well established. However, there is a paucity of information on local ADRs, especially in the Indian population. Objectives: This study aimed to determine the prevalence, severity, pre Read More

Background: The coronavirus disease 2019 (COVID128;19) was first reported in December 2019 in Wuhan, China. Skin manifestations of COVID-19 have been reported sporadically. Staphylococcus aureus occurs after viral infection due to unregulated IFN-α. We designed this reported case to pay more attention to the rare skin manifestations following COVID-19. Case Report: The patient was a 12-month-old girl who presented Read More